AI Predicts Brain Tumor Recurrence Risk Using Standard Pathology Slides

Researchers at Mayo Clinic have published findings in The Lancet Digital Health, illustrating that artificial intelligence can analyze routine pathology slides to classify meningiomas, the most common primary brain tumor. This AI-driven method can predict a patient's risk of tumor recurrence, potentially offering a more cost-effective and faster alternative to current genetic testing methods.